A tranche of grant funding worth $3.7 million has been awarded to six manufacturers through the Advanced Manufacturing Growth Centre Commercialisation Fund.
A statement from industry minister Christian Porter highlighted Western Australian company Alcolizer, which is developing a rapid antigen-based Covid-19 test.
Alcolizer was awarded $742,363 to work with research and industry partners — combining breakthroughs from the University of Technology Sydney and hardware technologies developed by Alcolizer — to develop a new medical device called the Virulizer, able to produce a result for symptomatic and asymptomatic infectees in under ten minutes.
The Virulizer had previously earned a $150,000 grant from the Innovative Manufacturing CRC. Alcolizer’s core business is in breath tests for alcohol and other drugs. These tests are used by police, mine site operators and others.
Recipients (see the five others below) sharing in the $3.7 million are from the federal government’s six National Manufacturing Priorities.
AMGC Managing Director, Dr Jens Goennemann said, “These are not grants for grants sake. AMGC has fine-tuned the impact of its grant program over the past 5-years. We know what works and we know how to derive value for the manufacturer, the industry, and the taxpayer.”
Funding covers up to 50 per cent of a project’s cost, and is targeted at manufacturing businesses with a product between Technology Readiness Level 7 and 9.
The Commercialisation Fund was announced by former industry minister Karen Andrews only three months ago, and is budgeted at $30 million in total, meaning approximately $26 million in grants will be awarded in future.
Subscribe to our free @AuManufacturing newsletter here.